Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ludewig

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
European Journal of Immunology|March 31, 2000
Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitisT Suter, U Malipiero, L Otten, et al.
Aktuelle Urologie|October 2, 2004
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]L Prikler, E Scandella, Y Men, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse modelB Ludewig, S Freigang, M Jäggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cellsB Ludewig, K McCoy, M Pericin, et al.
European Journal of Immunology|February 13, 2001
Induction, binding specificity and function of human ICOSK C Beier, A Hutloff, A M Dittrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protectionK J Maloy, C Burkhart, G Freer, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
European Journal of Immunology|March 31, 2000
Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitisT Suter, U Malipiero, L Otten, et al.
Aktuelle Urologie|October 2, 2004
[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens]L Prikler, E Scandella, Y Men, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse modelB Ludewig, S Freigang, M Jäggi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2001
Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cellsB Ludewig, K McCoy, M Pericin, et al.
European Journal of Immunology|February 13, 2001
Induction, binding specificity and function of human ICOSK C Beier, A Hutloff, A M Dittrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protectionK J Maloy, C Burkhart, G Freer, et al.
Pageof 3